cjc 1295 ipamorelin vs aod 9604 CJC-1295 No DAC & aod 9604 cjc 1295 ipamorelin

IGF-1 levels measured at the 12-week lab review typically confirm that the protocol is producing the expected physiological response

However, its essential to undergo Sermorelin therapy under the supervision of a medical professional to ensure proper dosing and to monitor for potential side effects, ensuring the safest and most effective outcomes

Wipe vial stopper with an alcohol swab before each use

Water Retention and GH-Mediated Fluid Effects Water retention and mild peripheral edema represent a documented side effect category in GHRP-6 research that is understood to be a downstream consequence of elevated GH activity rather than a direct effect of the peptide itself